Banu ALPASLAN MESCİ, et al. “Can Pentraxin-3 Be a Candidate Marker in the Follow-Up of the Patients With Behçet’s Disease?”. Archives of Rheumatology, vol. 32, no. 2, June 2017, pp. 091-5, doi:10.5606/ArchRheumatol.2017.6129.